Your statement about "huge batches of totally unrelated studies" is completely false.
All studies on c19ivermectin.com are directly related to Ivermectin efficacy versus SAR-Cov-2, a small number relate to Ivermectins viral efficacy in general.
Hot off the press (all peer-reviewed):
Ivermectin SARS-Cov-2 binding:
https://link.springer.com/article/10.1007/s13721-021-00299-2
https://www.frontiersin.org/articles/10.3389/fmicb.2020.5929...
https://www.nature.com/articles/s42003-020-01577-x
Ivermectin in humans, versus COVID-19:
768 outpatients, prospective trial vs control, significant improvement:
https://www.sciencedirect.com/science/article/pii/S120197122...
Infections - 0 of 788 treated, versus 237 of 407 in control group:
https://medicalpressopenaccess.com/upload/1605709669_1007.pd...
Retrospective, 3099 infected patients treated, 1 death:
https://www.longdom.org/open-access/the-use-of-compassionate...
Examples of counter-studies against Ivermecitn or HCQ (similar profile and response) in journals you love:
https://jamaletter.com/
The infamous Lancet front-page retrospective observational study on HCQ which turned out to be based on zero verifiable data, despite passing Lancet's "peer-review". (Sorry no link, it's been retracted.)